MPM Capital cites Baxter, Pfizer as reasons for move to Kendall Square

After a decade in Boston, the life science-focused venture firm MPM Capital is moving back to Kendall Square on the heels of drug giants like Baxter and Pfizer, which are also moving into the center of the global hub of biotech development...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.